Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2018

Open Access 01-12-2018 | Research article

Heart rate in patients with reduced ejection fraction: relationship between single time point measurement and mean heart rate on prolonged implantable cardioverter defibrillator monitoring

Authors: Marlena V. Habal, Kumaraswamy Nanthakumar, Peter C. Austin, Cassandra Freitas, Christopher Labos, Douglas S. Lee

Published in: BMC Cardiovascular Disorders | Issue 1/2018

Login to get access

Abstract

Background

Heart rate (HR) is a prognostic marker that is increasingly used as a therapeutic target in patients with cardiovascular disease. The association between resting and mean HR remains unclear. We therefore set out to determine the relationship between resting HR on the electrocardiogram (ECG) obtained at a single time point, and mean HR on implantable cardioverter defibrillator (ICD) interrogation amongst patients with a reduced left ventricular ejection fraction (LVEF).

Methods

Prospective ICD data were obtained from 54 patients with LVEF < 40%. Mean HR determined using the ICD HR histograms was compared with resting HR measured on the ECG performed in the clinic.

Results

Average resting and ICD mean HRs were 67.9 ± 10.1 and 67.8 ± 9.6 bpm respectively. There was good correlation in the overall cohort (r = 0.79), in those with resting ECG HRs ≤ 70 bpm (r = 0.62), and amongst the 27 patients on intermediate-to-high dose beta-blockers (r = 0.91). However, Bland-Altman analysis demonstrated wide limits of agreement in the overall cohort (− 12.5, 12.7 bpm), at resting HRs ≤ 70 bpm (− 12.7, 9.8 bpm), and on intermediate-to-high dose beta-blockers (− 8.9, 7.4 bpm). Moreover, resting HR did not predict the 10-bpm interval where the most time was spent.

Conclusions

While resting HR correlated with mean HR in patients with reduced LVEF, and in important subgroups, the limits of agreement were unacceptably wide raising concern over the use of single time point resting HR as a therapeutic target.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jensen MT, Marott JL, Allin KH, Nordestgaard BG, Jensen GB. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City heart study. Eur J Prev Cardiol. 2012;19(1):102–8.CrossRefPubMed Jensen MT, Marott JL, Allin KH, Nordestgaard BG, Jensen GB. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City heart study. Eur J Prev Cardiol. 2012;19(1):102–8.CrossRefPubMed
2.
go back to reference Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736–49.CrossRefPubMed Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736–49.CrossRefPubMed
3.
go back to reference Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005;352:1951–8.CrossRefPubMed Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005;352:1951–8.CrossRefPubMed
4.
go back to reference Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol. 1990;65:547–53.CrossRefPubMed Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol. 1990;65:547–53.CrossRefPubMed
5.
go back to reference Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26:967–74.CrossRefPubMed Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26:967–74.CrossRefPubMed
6.
go back to reference Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease. Am J Cardiol. 2010;105:905–11.CrossRefPubMed Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease. Am J Cardiol. 2010;105:905–11.CrossRefPubMed
7.
go back to reference Habal MV, Liu PP, Austin PC, Ross HJ, Newton GE, Wang X, et al. Association of Heart Rate at hospital discharge with mortality and hospitalizations in patients with heart failure. Circ Heart Fail. 2014;7:12–20.CrossRefPubMed Habal MV, Liu PP, Austin PC, Ross HJ, Newton GE, Wang X, et al. Association of Heart Rate at hospital discharge with mortality and hospitalizations in patients with heart failure. Circ Heart Fail. 2014;7:12–20.CrossRefPubMed
9.
go back to reference Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Michelson EL, et al. Association of Heart Rate and Outcomes in a broad Spectrum of patients with chronic heart failure. J Am Coll Cardiol. 2012;59:1785–95.CrossRefPubMed Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Michelson EL, et al. Association of Heart Rate and Outcomes in a broad Spectrum of patients with chronic heart failure. J Am Coll Cardiol. 2012;59:1785–95.CrossRefPubMed
10.
go back to reference Perski A, Olsson G, Landou C, de Faire U, Theorell T, et al. Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J. 1992;123:609–16.CrossRefPubMed Perski A, Olsson G, Landou C, de Faire U, Theorell T, et al. Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J. 1992;123:609–16.CrossRefPubMed
11.
go back to reference Heidland UE, Stauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation. 2001;104:1477–82.CrossRefPubMed Heidland UE, Stauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation. 2001;104:1477–82.CrossRefPubMed
12.
go back to reference Borer JS, Fox K, Jaillon P, Lerebours G. Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina. A randomized, double-blind, multicentered, placebo-controlled trial. Circulation. 2003;107:817–23.CrossRefPubMed Borer JS, Fox K, Jaillon P, Lerebours G. Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina. A randomized, double-blind, multicentered, placebo-controlled trial. Circulation. 2003;107:817–23.CrossRefPubMed
13.
go back to reference Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, et al. SHIFT investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomized placebo-controlled trial. Lancet. 2010;376:886–94.CrossRefPubMed Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, et al. SHIFT investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomized placebo-controlled trial. Lancet. 2010;376:886–94.CrossRefPubMed
14.
go back to reference Howlett J, Chan M, Ezekowitz J, Harkness K, Heckman G, Kouz S, et al. The Canadian cardiovascular society heart failure companion: bridging guidelines to your practice. Can J Cardiol. 2016;32:296–310.CrossRefPubMed Howlett J, Chan M, Ezekowitz J, Harkness K, Heckman G, Kouz S, et al. The Canadian cardiovascular society heart failure companion: bridging guidelines to your practice. Can J Cardiol. 2016;32:296–310.CrossRefPubMed
15.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-200. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-200.
16.
go back to reference Palatini P, Winnicki M, Santonastaso M, De Venuto G, Zanata G, Bertolo O, et al. Reproducibility of heart rate measured in the clinic and with 24-hour intermittent recorders. Am J Hypertens. 2000;13:92–8.CrossRefPubMed Palatini P, Winnicki M, Santonastaso M, De Venuto G, Zanata G, Bertolo O, et al. Reproducibility of heart rate measured in the clinic and with 24-hour intermittent recorders. Am J Hypertens. 2000;13:92–8.CrossRefPubMed
17.
go back to reference Carlson N, Dixen U, Marott JL, Jensen MT, Jensen GB. Predictive value of casual ECG-based resting heart rate compared with resting heart rate obtained from Holter recording. Scand J Clin Lab Invest. 2014;74:163–9.CrossRefPubMed Carlson N, Dixen U, Marott JL, Jensen MT, Jensen GB. Predictive value of casual ECG-based resting heart rate compared with resting heart rate obtained from Holter recording. Scand J Clin Lab Invest. 2014;74:163–9.CrossRefPubMed
18.
go back to reference Lieback A, Proff J, Weeel K, Fleck E, Gotze S. Remote monitoring of heart failure patients using implantable cardiac pacing devices and external sensors: results of the insight-HF study. Clin Res Cardiol. 2012;101:101–7.CrossRefPubMed Lieback A, Proff J, Weeel K, Fleck E, Gotze S. Remote monitoring of heart failure patients using implantable cardiac pacing devices and external sensors: results of the insight-HF study. Clin Res Cardiol. 2012;101:101–7.CrossRefPubMed
20.
go back to reference Fox K, Ford I, Steg PG, Tardif M, Ferrari R, et al. Ivabradine in stable coronary artery disease without clinical heart failure. NEJM. 2014;371:1091–9.CrossRefPubMed Fox K, Ford I, Steg PG, Tardif M, Ferrari R, et al. Ivabradine in stable coronary artery disease without clinical heart failure. NEJM. 2014;371:1091–9.CrossRefPubMed
21.
go back to reference Fox K, Ford I, Steg PG, Tendera M, Ferrari R, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet. 2008;372:807–16.CrossRefPubMed Fox K, Ford I, Steg PG, Tendera M, Ferrari R, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet. 2008;372:807–16.CrossRefPubMed
22.
go back to reference Goldberger JJ, Bonow RO, Cuffe M, Liu L, Rosenberg Y, et al. Effect of Beta-blocker dose on survival after acute myocardial infarction. J Am Coll Cardiol. 2015;66:1431–41.CrossRefPubMedPubMedCentral Goldberger JJ, Bonow RO, Cuffe M, Liu L, Rosenberg Y, et al. Effect of Beta-blocker dose on survival after acute myocardial infarction. J Am Coll Cardiol. 2015;66:1431–41.CrossRefPubMedPubMedCentral
23.
go back to reference Jolly US, Klein G. Utility of ambulatory Holter monitoring in patients with permanent Atrial fibrillation. Can J Cardiol. 2015;31:S246.CrossRef Jolly US, Klein G. Utility of ambulatory Holter monitoring in patients with permanent Atrial fibrillation. Can J Cardiol. 2015;31:S246.CrossRef
24.
go back to reference Pastor-Perez FJ, Manzano-Fernandez S, Goya-Esteban R, Pascual-Figal DA, Bravo IP, Barquero-Perez O, et al. Heart rate control in chronic heart failure: resting versus mean heart rate with prolonged ambulatory ECG recording. Int J Cardiol. 2013;170:e45–7.CrossRefPubMed Pastor-Perez FJ, Manzano-Fernandez S, Goya-Esteban R, Pascual-Figal DA, Bravo IP, Barquero-Perez O, et al. Heart rate control in chronic heart failure: resting versus mean heart rate with prolonged ambulatory ECG recording. Int J Cardiol. 2013;170:e45–7.CrossRefPubMed
25.
go back to reference Dharod A, Soliman EZ, Dawood F, Chen H, Shea S, et al. Association of Asymptomatic Bradycardia with Incident Cardiovascular Disease and Mortality: the multi-ethnic study of atherosclerosis. JAMA Intern Med. 2016;176:219–27.CrossRefPubMed Dharod A, Soliman EZ, Dawood F, Chen H, Shea S, et al. Association of Asymptomatic Bradycardia with Incident Cardiovascular Disease and Mortality: the multi-ethnic study of atherosclerosis. JAMA Intern Med. 2016;176:219–27.CrossRefPubMed
26.
go back to reference Wilkoff B, Cook J, Epstein A, Greene HL, Hallstrom AP, Hsia H, et al. Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA. 2002;288(24):2123–3115.CrossRefPubMed Wilkoff B, Cook J, Epstein A, Greene HL, Hallstrom AP, Hsia H, et al. Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA. 2002;288(24):2123–3115.CrossRefPubMed
Metadata
Title
Heart rate in patients with reduced ejection fraction: relationship between single time point measurement and mean heart rate on prolonged implantable cardioverter defibrillator monitoring
Authors
Marlena V. Habal
Kumaraswamy Nanthakumar
Peter C. Austin
Cassandra Freitas
Christopher Labos
Douglas S. Lee
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2018
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-018-0751-2

Other articles of this Issue 1/2018

BMC Cardiovascular Disorders 1/2018 Go to the issue